Impact in Your Community, Respond Now

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

Health challenges can affect individuals at any stage of life, but the likelihood of complications rises significantly with age.

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.